119 related articles for article (PubMed ID: 29057763)
1. Vasohibin-1 Is a Poor Prognostic Factor of Ovarian Carcinoma.
Sano R; Kanomata N; Suzuki S; Shimoya K; Sato Y; Moriya T; Shiota M
Tohoku J Exp Med; 2017 Oct; 243(2):107-114. PubMed ID: 29057763
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma.
Miyazaki Y; Kosaka T; Mikami S; Kikuchi E; Tanaka N; Maeda T; Ishida M; Miyajima A; Nakagawa K; Okada Y; Sato Y; Oya M
Clin Cancer Res; 2012 Aug; 18(15):4145-53. PubMed ID: 22675166
[TBL] [Abstract][Full Text] [Related]
3. Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma.
Kanomata N; Sato Y; Miyaji Y; Nagai A; Moriya T
J Clin Pathol; 2013 Jul; 66(7):613-9. PubMed ID: 23543668
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of vasohibin-1 expression in patients with prostate cancer.
Kosaka T; Miyazaki Y; Miyajima A; Mikami S; Hayashi Y; Tanaka N; Nagata H; Kikuchi E; Nakagawa K; Okada Y; Sato Y; Oya M
Br J Cancer; 2013 May; 108(10):2123-9. PubMed ID: 23591203
[TBL] [Abstract][Full Text] [Related]
5. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
[TBL] [Abstract][Full Text] [Related]
6. Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients.
Mikami S; Oya M; Kosaka T; Mizuno R; Miyazaki Y; Sato Y; Okada Y
Lab Invest; 2017 Jul; 97(7):854-862. PubMed ID: 28287633
[TBL] [Abstract][Full Text] [Related]
7. Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
Torii C; Hida Y; Shindoh M; Akiyama K; Ohga N; Maishi N; Ohiro Y; Ono M; Totsuka Y; Kitagawa Y; Tei K; Sato Y; Hida K
Anticancer Res; 2017 Mar; 37(3):1219-1225. PubMed ID: 28314285
[TBL] [Abstract][Full Text] [Related]
8. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.
Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L
Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406
[TBL] [Abstract][Full Text] [Related]
9. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M
Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
[TBL] [Abstract][Full Text] [Related]
11. The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.
Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
Int J Oncol; 2015 Dec; 47(6):2057-63. PubMed ID: 26460696
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma.
Zhao G; Yang Y; Tang Y; Han R; Sun Y
Med Oncol; 2012 Dec; 29(5):3325-34. PubMed ID: 22865127
[TBL] [Abstract][Full Text] [Related]
13. FGF18 as a potential biomarker in serous and mucinous ovarian tumors.
El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA
Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667
[TBL] [Abstract][Full Text] [Related]
14. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
[TBL] [Abstract][Full Text] [Related]
15. Expression of Vasohibin-1 in Human Carotid Atherosclerotic Plaque.
Fukumitsu R; Minami M; Yoshida K; Nagata M; Yasui M; Higuchi S; Fujikawa R; Ikedo T; Yamagata S; Sato Y; Arai H; Yokode M; Miyamoto S
J Atheroscler Thromb; 2015; 22(9):942-8. PubMed ID: 25843115
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of vasohibin-1 in esophageal carcinoma cells: Inhibition of cell growth and migration.
Ma D; Li J; Wang J; Sun Z; Wang K
Mol Med Rep; 2017 Aug; 16(2):1479-1485. PubMed ID: 29067450
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma.
Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y
Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370
[TBL] [Abstract][Full Text] [Related]
18. Is vasohibin-1 for more than angiogenesis inhibition?
Sato Y
J Biochem; 2011 Mar; 149(3):229-30. PubMed ID: 21217147
[TBL] [Abstract][Full Text] [Related]
19. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
[TBL] [Abstract][Full Text] [Related]
20. Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer.
Kobayashi H; Kosaka T; Mikami S; Miyazaki Y; Matsumoto K; Kikuchi E; Miyajima A; Kameyama K; Sato Y; Oya M
Oncotarget; 2018 Feb; 9(12):10203-10210. PubMed ID: 29535800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
